Cargando…
EvaLuation of early CRRT and beta-blocker InTervention in patients with ECMO (ELITE) trial: study protocol for a 2 × 2 partial factorial randomized controlled trial
BACKGROUND: In critically ill patients requiring extracorporeal membrane oxygenation (ECMO) therapy, early initiation of continuous renal replacement therapy (CRRT) and beta-blockade of catecholamine-induced inotropic effects may improve outcomes. METHODS: A 2 × 2 partial factorial randomized contro...
Autores principales: | Wang, Xiaofang, Wang, Hong, Du, Xin, Wang, Zhiyan, Li, Chenglong, Anderson, Craig S., Zhang, Jinying, Hou, Xiaotong, Dong, Jianzeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389730/ https://www.ncbi.nlm.nih.gov/pubmed/35986410 http://dx.doi.org/10.1186/s13063-022-06617-x |
Ejemplares similares
-
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial
por: Hockham, Carinna, et al.
Publicado: (2021) -
EvaLuation of Interventions for informed Consent for randomIsed controlled Trials (ELICIT): developing a core outcome set
por: Gillies, Katie, et al.
Publicado: (2015) -
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial
por: McGree, J. M., et al.
Publicado: (2022) -
Impact of CRRT in Patients with PARDS Treated with VV-ECMO
por: Redant, Sébastien, et al.
Publicado: (2021) -
ECMO and CRRT “All in One!” in COVID-19 Era
por: Condello, Ignazio, et al.
Publicado: (2023)